Dr Russel Medford
Director
CESCA A Boyalife Company.
China
Biography
Dr. Medford was appointed to the board in February 2017. He is a managing partner of the Salutramed Group, LLC, a life sciences management consultancy, and has extensive private and public company expertise. He also serves as chief executive officer of healthEgames, Inc., a digital healthcare company and serves as the executive chairman of ViaMune, Inc., an immuno-oncology company. Dr. Medford has served as the co-founder, president, chief executive officer and director of AtheroGenics, Inc. and was a founding board member of Inhibitex, Inc., serving on its board until its acquisition by Bristol-Myers Squibb in 2012. He has led companies through multiple stages of research and development, advancing novel, first-in-man clinical candidates for the treatment of cardiovascular disease, diabetes and arthritis. Dr. Medford obtained his M.D. and Ph.D. from the Albert Einstein College of Medicine.
Research Interest
Business and Management.
